N,N-dimethylacetamide targets neuroinflammation in Alzheimer’s disease in in-vitro and ex-vivo models

Alzheimer’s disease (AD) is a chronic degenerative brain disorder with no clear pathogenesis or effective cure, accounting for 60–80% of cases of dementia. In recent years, the importance of neuroinflammation in the pathogenesis of AD and other neurodegenerative disorders has come into focus. Previo...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Zeng-Hui, Koya, Jagadish, Acharekar, Nikita, Trejos, Jesus, Dong, Xing-Duo, Schanne, Francis A., Ashby, Charles R., Reznik, Sandra E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151369/
https://www.ncbi.nlm.nih.gov/pubmed/37127686
http://dx.doi.org/10.1038/s41598-023-34355-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10151369/
https://www.ncbi.nlm.nih.gov/pubmed/37127686
http://dx.doi.org/10.1038/s41598-023-34355-w

Ejemplares similares